` CMND (Clearmind Medicine Inc) vs S&P 500 Comparison - Alpha Spread

C
CMND
vs
S&P 500

Over the past 12 months, CMND has underperformed S&P 500, delivering a return of -94% compared to the S&P 500's +14% growth.

Stocks Performance
CMND vs S&P 500

Loading
CMND
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CMND vs S&P 500

Loading
CMND
S&P 500
Difference
www.alphaspread.com

Performance By Year
CMND vs S&P 500

Loading
CMND
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Clearmind Medicine Inc vs Peers

S&P 500
CMND
AMGN
ARGX
ALNY
603259
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Clearmind Medicine Inc
Glance View

Market Cap
164.4m USD
Industry
N/A

Clearmind Medicine, Inc. operates as a mineral resource company, which acquires, explores, develops, and operates mineral resource assets in Canada. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-05-15. The firm is focused on the discovery and development of novel psychedelic derived therapeutics to solve health problems including alcohol use disorder. The firm is engaged in the research and development of compounds derived from psychedelics and commercializes them as regulated medicines, foods, or supplements. The firm's portfolio consists of patent families such as binge behavior regulators and alcoholic beverage substitutes.

CMND Intrinsic Value
Not Available
C
Back to Top